bullish
Frontage Holdings IPO: Bull/Bear Case DCF Scenarios
638 Views30 May 2019 01:07
Frontage Holdings (1521 HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347 CH)....
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Pharmaron Beijing IPO: H-Share Valuation Enticing14 Nov 2019
- Pharmaron Beijing IPO: Solid 9M19, but Is It Good Enough?04 Nov 2019
- Pharmaron Beijing IPO Initiation: Clinically Sound29 Aug 2019
- Frontage Holdings IPO: Risk-Reward Is Favourable at the Low-End of Price Range15 May 2019
- Frontage Holdings IPO Preview: An Uncertain Transition08 May 2019
- Viva Biotech IPO Preview: Show Me the Money22 Apr 2019
x